On Sunday, September 10, we held our inaugural Pink on the River Brunch at RPM Events in Chicago. The event was an overwhelming success, raising over $250,000 for life-saving breast cancer research and Giuliana Rancic's FAB-U-WISH program! The afternoon was hosted by Giuliana and Bill Rancic and had a one-of-a-kind silent auction that featured over 70 items, including unique experiences, elegant dinners, sports outings, chic fashion accessories, and more.

A huge thank you to our co-chairs, our host committee, our sponsors, and our passionate crowd of nearly 400 guests. The success of this event would not have been possible without your steadfast dedication to The Pink Agenda's mission. Together, we will make breast cance history.



We are thrilled to back at Tribeca Rooftop on Thursday, October 5 at 7:30 PM for The Pink Agenda’s Annual Gala! Blame it on the boogie but we can't wait for you to join us as we party for a purpose and raise money, raise awareness, and raise hell for life-saving breast cancer research.

The evening will feature music by KOCH and include a presentation of The Pink Agenda Icon Award to our long-time partner Speed Rack for their passion and unwavering dedication to the breast cancer community. Speed Rack is the first global competition of its kind to highlight the bar industry’s leading womxn+, with 100% of proceeds going directly to breast cancer education, prevention, and research. The award will be presented by Cooper Cheatham, proprietor of Double Barrel Consulting and founder of The Gay & Lesbian Alliance for Spirited Sipping (GLASS), the first LGBT hospitality organization that unites LGBT spirits & hospitality professionals across the country.


Join us at the historic Fox Theatre, our exciting new venue, for The Pink Agenda’s Atlanta Galaon Thursday, October 26 at 7:00 PM! Enjoy an evening of fun, philanthropy, and celebration with great food, music, and a fabulous silent auction!


In 2023, we have had the privilege of funding four researchers through TPA's partnership with the Breast Cancer Research Foundation. The scientific strides our researchers have made in the past year alone is greatly encouraging, and we're pleased to share their progress with you below.

Dr. Susan Domchek aims to enhance genetic testing for those with a personal and family history of breast and other cancers. Dr. Domchek and her team made significant strides in establishing protocols for efficient and effective genetic testing for BRCA1 and BRCA2. The presence of a BRCA mutation allows doctors to estimate cancer risks, develop a screening and prevention plan, and use targeted therapies for cancers that develop. The results of these studies are fully published, and these tools have transitioned from research to the clinical care setting.


Dr. Dawn Hershman aims to identify ways to improve cancer care delivery, quality of care, and quality of life for patients with breast cancer. Dr. Hershman and her team have shown that the blood glucose levels are elevated (hyperglycemia) in patients during chemotherapy treatment, and her results have suggested an association between the hyperglycemia and chemotherapy- induced peripheral neuropathy. The team has developed a prospective intervention to more tightly control glucose levels to reduce complications from hyperglycemia.

Dr. Neil Iyengar aims to develop risk-stratification algorithms to individual lifestyle interventions to reduce complications for breast cancer patients. Dr. Iyengar and his team discovered that obesity and metabolic dysfunction are associated with breast fat inflammation, tumor growth, and cancer recurrence. He also identified several common modifiable lifestyle risk factors including sedentary lifestyle, dietary patterns that do not meet national guidelines, sleep disturbances, and lack of psychosocial support that are present at the time of cancer diagnosis, which allowed for intervention near the start of cancer treatment.


Dr. Ann Partridge aims to advance the understanding of medical and emotional problems faced by young women with breast cancer. The Young Women’s Breast Cancer Study (YWS) study enrolled over 1,300 women with newly diagnosed breast cancer between 2006 and 2016, representing 60% of women invited through select centers in North America. Through these studies, the team has discovered distinct genomic features in young women compared to older women and many therapeutic targets that warrant further investigation. To learn more about our impact and the current research projects we are funding, visit today.



The Pink Agenda is proud to be an official charity partner of the 2023 TCS New York City Marathon. Our marathon runners have raised over $110,000 so far this year and over $1 million in total for breast cancer research! Running 26.2 miles isn’t easy, but neither is undergoing breast cancer treatment or eradicating the disease.